Roche CFO Says Co. Commited to Genentech (DNA) Deal -Reuters
Reuters is reporting that Roche's (OTC: RHHBY) CFO, Erich Hunziker, has made comments saying that Roche is committed to the Genentech (NYSE: DNA) transaction.
Genentech, Inc. engages in the discovery, development, manufacture, and commercialization of pharmaceutical products in the United States.
Create E-mail AlertRelated Categories
Corporate NewsMergers and Acquisitions
Trader Talk
Stocks Mentioned
+0.00
-0.76Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
